Robert Benschop

Eli Lilly and Company
Indianapolis, IN, United States

Immunologist, specializing in translational science in pharmaceutical industry.

Presentation(s):

• 2176: Cellular and Proteomic Changes Following Administration of Peresolimab, in a Phase 2a Trial in Rheumatoid Arthritis

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.